Beauty giants test treatments for "Ozempic face": what doctors say
- Galderma, L'Oréal and Natura are testing treatments for facial sagging and volume loss in weight-loss drug users.
- Experts say facial volume loss is linked to rapid weight loss rather than GLP-1 drugs themselves.
- Dermatologists say creams cannot reach the deep fat layer the face loses, and injectable fillers work better.
- Boston Consulting Group estimates revenue from these treatments could grow from about $700 million to $2 billion in five years.
Reuters reported on 21 October 2026 that Swiss skincare firm Galderma, Brazilian group Natura and L'Oréal are testing treatments for facial sagging and volume loss after weight loss with GLP-1 drugs, a concern known as "Ozempic face".
Is the drug to blame?
Experts say facial volume loss is linked to rapid weight loss rather than to GLP-1 drugs themselves. Washington facial plastic surgeon Michael Somenek said losing a large amount of weight over four to six months can clearly affect facial volume. King's College London dermatologist Beibei Du-Harpur called the term misleading: "The drug doesn't melt your collagen," she said, adding that slower weight loss would reduce some of the more severe changes.
Also read: Study: US rules on Botox and filler injections vary widely by state, and some states have none
Other factors
GLP-1 drugs are used most by adults aged 50 to 64, a group already losing collagen, and menopausal women also see falling oestrogen. Some clinicians noted that poor nutrition among some users may affect skin too.
Creams or fillers?
Doctors say creams can improve skin appearance but cannot replace the deep fat layer the face loses or change its ligament structure. Injectable treatments such as fillers reach deeper and work better for lost volume. Boston Consulting Group estimates revenue from these clinical treatments could grow from about $700 million to $2 billion over five years.
Source: Reuters via CTV News
This story is relayed from the source named above; responsibility for its content rests with the original source.
FAQ
What is "Ozempic face"?
"Ozempic face" describes facial sagging and volume loss after rapid weight loss with GLP-1 drugs such as Ozempic and Wegovy.
Do GLP-1 drugs directly cause "Ozempic face"?
Experts say "Ozempic face" is linked to rapid weight loss rather than GLP-1 drugs themselves, and the drug does not melt collagen.
Which companies are testing treatments for "Ozempic face"?
Galderma, L'Oréal and Natura are testing treatments for "Ozempic face", Reuters reported in October 2026.
Can creams treat "Ozempic face"?
Dermatologists say creams may improve skin appearance but cannot replace the deep facial fat lost in "Ozempic face".
How can the risk of "Ozempic face" be reduced?
Doctors say slower, more sustainable weight loss reduces some of the more severe changes associated with "Ozempic face".



